How to Prevent Muscle Loss on Ozempic, Wegovy or Zepbound (2026)

How Much Muscle Do You Actually Lose on Ozempic or Mounjaro?

About 25% of the weight lost on a GLP-1 drug is lean mass and 75% is fat, according to the STEP 1 and SURMOUNT-1 DXA substudies (Look et al., 2025).

The data is more nuanced than headlines suggest.

In the STEP 1 DXA substudy (semaglutide 2.4 mg, 95 participants scanned at baseline and 68 weeks), total lean body mass decreased by 9.7% from baseline. But total fat mass dropped by 19.3%, and visceral fat dropped by 36%. The proportion of lean mass relative to total body weight actually increased by 3.0 percentage points. In absolute terms, participants lost about 10.4 kg of fat and 5.3 kg of lean mass (Wilding et al., J Endocr Soc, 2021).

In the SURMOUNT-1 DXA substudy (tirzepatide, 160 paired scans at baseline and 72 weeks), body weight fell 21.3%, fat mass fell 33.9%, and lean mass fell 10.9%. Approximately 75% of the weight lost was fat and 25% was lean. A ratio that was consistent across the 5, 10, and 15 mg dose groups and was similar between tirzepatide and placebo (Look et al., Diabetes Obes Metab, 2025).

A 2026 comprehensive review in Metabolites summarized the picture: semaglutide and tirzepatide "preferentially reduce fat mass, including visceral and ectopic adiposity, while producing smaller but consistent reductions in lean mass." The key message is that body composition improves overall — but lean mass does go down, and for people already at risk of sarcopenia (older adults, women in perimenopause, sedentary individuals), that decline matters (Šantić et al., Metabolites, 2026).

Why Does Lean Mass Drop?

The mechanism is straightforward: you are in a significant calorie deficit. GLP-1 drugs reduce appetite by 20–35%, and when you eat less, your body breaks down both fat and some muscle for energy. This is not unique to GLP-1 drugs, the same 75:25 fat-to-lean ratio is seen in calorie-restricted dieting, and after bariatric surgery the lean-mass share can be even higher.

Three factors make the lean-mass problem worse on a GLP-1:

Protein intake drops alongside everything else. When total food volume falls 20–35%, protein intake often falls proportionally. Even though protein needs stay the same or increase during weight loss. The 2025 Joint Advisory specifically flags this: protein is the single most important macronutrient for muscle preservation, and most GLP-1 users are not eating enough of it.

Most users are not resistance training. A 2026 ClinicalTrials.gov-registered survey (NCT07702461) was designed specifically to quantify this gap — the researchers note that "little is known about patients' RT behavior before and after initiating GLP-1RA therapy." Exercise is the strongest stimulus for muscle protein synthesis, and without it, even adequate protein cannot fully prevent lean-mass loss.

Older adults and women are more vulnerable. Age-related decline in muscle protein synthesis means that every kilogram of lean mass lost is harder to rebuild after 50. Women start with less muscle mass and lower testosterone, so the same percentage loss has greater functional impact. The LEAN-PREP trial protocol explicitly targets this group.

What the Experts Recommend: The Joint Advisory

In 2025, four major US medical societies, the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Jointly published nutritional priorities for GLP-1 therapy. Their recommendations on lean mass preservation are clear (Mozaffarian et al., Obes Pillars, 2025):

Protein: 1.2–1.6 g per kg of body weight per day, distributed across meals. For a 180-lb person, that is 98–131 g/day. The advisory notes that "protein intake alone is likely inadequate to prevent lean mass loss without concurrent resistance exercise."

Resistance training: Structured resistance exercise at least 2–3 times per week, targeting major muscle groups. The advisory describes this as a "non-negotiable" component of lean mass preservation.

Monitoring: Regular assessment of body composition and physical function, not just scale weight. Grip strength, chair-stand tests, and walking speed are simple functional indicators.

The 5-Part Muscle Preservation Protocol

The five steps are resistance training (the non-negotiable), high protein intake (1.2-1.6 g/kg/day), creatine monohydrate (3-5 g daily), vitamin D and magnesium, and adequate hydration.

The five steps that preserve muscle on a GLP-1 are resistance training, high protein intake, creatine, vitamin D and magnesium, and adequate hydration. Resistance training and protein carry the most evidence; the rest are supporting players.

1. Resistance Training: The Non-Negotiable

This is the single highest-impact intervention. No supplement, protein shake, or dietary strategy matches what lifting does for muscle preservation during weight loss.

Several registered clinical trials are now testing resistance training during GLP-1 therapy, including LEAN-PREP (232 participants, Dasman Diabetes Institute; NCT06885736) and FLEX (University of Exeter, tirzepatide in women with overweight or obesity; NCT07457437). The field is taking this seriously.

Minimum effective dose: 2–3 sessions per week, each hitting major muscle groups (legs, back, chest, shoulders, arms). Compound movements. Squats, deadlifts, rows, presses — are the most efficient. Home-based programs with resistance bands and bodyweight exercises are effective; the LEAN-PREP trial uses exactly this approach. You do not need a gym membership.

Progression matters: Gradually increase resistance or volume over time. If you can easily complete 3 sets of 12 reps, increase the weight. The stimulus for muscle preservation comes from progressive overload, not just going through the motions.

2. Protein-First Eating

On a suppressed appetite, every bite counts. Protein-first eating means starting every meal with the protein source before touching carbs or fat.

Target: 1.2–1.6 g/kg/day, which translates to roughly 25–40 g per meal across 3–4 eating occasions. The LEAN-PREP trial protocol targets 1.6 g/kg/day in its protein-supplementation arm.

Best sources when appetite is low: Greek yogurt (17 g per cup), eggs (6 g each), cottage cheese (14 g per half cup), whey protein shake (25–30 g per scoop), chicken breast (31 g per 4 oz), canned tuna (20 g per can). Liquids are often easier to consume than solids when GI side effects are active.

Leucine threshold: The amino acid leucine is the primary trigger for muscle protein synthesis. Each meal needs at least 2.5–3 g of leucine to "turn on" the synthesis machinery. Animal proteins and whey clear this threshold easily; plant proteins (except soy) often need a larger serving.

3. Creatine Monohydrate

Creatine is the most studied ergogenic supplement in sports nutrition. (For how to choose one, see our tested creatine brand rankings and complete creatine guide.) The ISSN calls it "the most effective ergogenic nutritional supplement currently available" for lean mass and strength. While no GLP-1-specific trial has been published yet, the indirect evidence is strong.

The 2026 Metabolites review on lean mass preservation during GLP-1 therapy evaluated creatine as a potential adjunct and noted: "Two independent 2025 meta-analyses of older adults undergoing resistance training found that creatine supplementation produced modest but consistent improvements in lean tissue mass and muscular strength." This builds on a foundational meta-analysis of 357 older adults showing creatine plus resistance training increased fat-free mass more than training alone (Devries & Phillips, Med Sci Sports Exerc, 2014), and a 2026 three-level meta-analysis confirming modest strength gains in adults aged 60+ (Yao et al., Front Nutr, 2026). The review classifies it as an "optional adjunct with resistance training" with "limited indirect" evidence in the GLP-1 context.

A Vanderbilt University Medical Center trial (NCT07760948) is set to test HMB plus vitamin D in older adults starting semaglutide, with appendicular lean mass and bone density as outcomes. It is one of the first controlled supplement trials designed specifically for GLP-1 users.

Dose: 3–5 g of creatine monohydrate daily. No loading phase is needed. Daily intake reaches muscle saturation within 3–4 weeks. Take it with a meal. The hydration component in a creatine + electrolyte formula is a bonus for GLP-1 users, who often underdrink due to appetite suppression.

4. Vitamin D and Micronutrients

Vitamin D receptors are present in skeletal muscle, and deficiency is associated with muscle weakness and higher fall risk in older adults. Given that GLP-1 users eat less and may get less sun exposure during weight loss, supplementation is a low-cost safeguard.

Dose: 1000–2000 IU vitamin D3 daily. Check 25-hydroxyvitamin D levels — target 40–60 ng/mL.

Magnesium is involved in over 300 enzymatic reactions including muscle contraction. Deficiency, present in roughly 50% of Americans. Can contribute to cramps, weakness, and poor recovery. 200–400 mg of magnesium glycinate daily supports muscle function and sleep quality, both of which help recovery from training.

5. Adequate Hydration

This is often overlooked. GLP-1 drugs reduce not just food intake but fluid intake — thirst decreases alongside appetite. Dehydration impairs exercise performance, reduces muscle protein synthesis rates, and can worsen the fatigue and dizziness that many GLP-1 users report.

Target: Minimum 64 oz (roughly 2 liters) daily, more on training days or in hot weather. An electrolyte-enhanced hydration formula is particularly useful because sweat losses during exercise need mineral replacement, and a creatine hydration powder serves both purposes simultaneously.

What "Ozempic Face" and Loose Skin Really Mean

"Ozempic face", the gaunt, hollowed-out appearance some users notice. Is primarily subcutaneous facial fat loss, not muscle loss. Facial fat pads shrink during rapid weight loss regardless of the method. However, muscle loss throughout the body can contribute to a less "toned" appearance and loose skin.

The best defense against both is slowing the rate of weight loss (when clinically appropriate) and maintaining muscle mass through the strategies above. Muscle provides the structural framework that keeps skin taut. Someone who loses 50 lbs while lifting heavy will look dramatically different from someone who loses 50 lbs on the couch — even at the same final weight.

The Special Risks for Older Adults

Adults over 60 lose muscle faster on GLP-1 drugs because they start with less muscle mass, have lower anabolic hormone levels, and are more susceptible to sarcopenia. Resistance training is even more critical in this group.

For adults over 60, muscle loss on a GLP-1 is not just cosmetic, it is a functional safety issue. Sarcopenia (age-related muscle loss) already costs older adults roughly 1–2% of muscle mass per year after 50. Adding a GLP-1-induced 10% lean mass reduction on top of that can push someone from independent to fall-prone.

The 2026 Metabolites review warns: "Do not equate DXA lean mass loss with sarcopenia without functional decline." But it also notes that lean mass loss "may matter in high-risk patients". Specifically older adults and those with existing functional limitations.

For older adults on GLP-1s: Resistance training is even more critical. Protein targets should be at the upper end of the range (1.4–1.6 g/kg/day). Creatine supplementation has its strongest evidence base in older adults. And functional testing (grip strength, chair stands, gait speed) should happen at baseline, 3 months, and 6 months — not just body weight checks.

Women in Perimenopause: A Double Vulnerability

Perimenopausal women face muscle loss from two directions simultaneously: the GLP-1 drug's caloric deficit and the estrogen decline that impairs muscle protein synthesis. The protocol is the same but the urgency is higher.

Women aged 40–55 face a compounding challenge: declining estrogen accelerates muscle loss, reduces muscle protein synthesis rates, and shifts fat distribution toward the abdomen. Adding a GLP-1 drug on top of these hormonal changes means the lean-mass stakes are higher.

Creatine may be particularly relevant here. A comprehensive review of creatine in aging adults found favorable effects on muscle, bone, and strength when combined with resistance training (Candow et al., Nutrients, 2021), with emerging interest in its benefits across the female lifespan, including perimenopause. The mechanism makes sense: creatine increases phosphocreatine stores in muscle, supports ATP regeneration during high-intensity effort, and may have neuroprotective effects that help with the brain fog many perimenopausal women report.

For more on this group, see our creatine guide for women and perimenopause supplement guide. For perimenopausal women on GLP-1 drugs, the protocol is the same but the urgency is higher: lift heavy, eat protein first, add creatine, and monitor functional strength, not just scale weight.

What Happens If You Don't Protect Your Muscle?

Losing muscle without protecting it lowers your metabolic rate, reduces strength and daily function, raises fall risk in older adults, and makes weight regain easier and fattier after you stop the drug. The worst outcome is not the number on the DXA scan, it is the functional decline behind it.

Losing 10% of lean mass translates to:

• Reduced metabolic rate (muscle burns more calories at rest than fat), making weight regain easier after stopping the drug
• Lower strength and endurance for daily activities
• Increased injury risk during exercise
• Higher fall risk in older adults
• "Skinny fat" body composition — lower scale weight but poor muscle-to-fat ratio

In the KFF November 2025 poll, 14% of GLP-1 users said they had stopped the drug because of cost, and 13% because of side effects. When people stop, weight regain is common, and regained weight tends to be disproportionately fat. If you lost muscle during treatment and regain fat afterward, you end up with worse body composition than where you started. Muscle preservation during treatment is insurance against this scenario.

Active Clinical Trials (Results Expected 2027–2029)

At least two registered clinical trials are testing whether targeted supplementation can preserve lean mass during GLP-1 therapy. Results expected 2027 will be the first controlled data on this question.

The scientific community is taking GLP-1 muscle loss seriously. At least six registered clinical trials are specifically studying muscle preservation strategies during GLP-1 therapy:

LEAN-PREP (NCT06885736): 232 adults, 4-arm RCT testing resistance exercise, protein, combined, or control during semaglutide/tirzepatide. Dasman Diabetes Institute. Recruiting.

FLEX (NCT07457437): University of Exeter. Progressive resistance exercise during tirzepatide in overweight/obese females. Recruiting.

HMB + Vitamin D (NCT07760948): Wake Forest. HMB + D3 during semaglutide in older adults with T2D. Includes muscle biopsy and D3-creatine dilution. 2026.

Structured Exercise + Tirzepatide (NCT07609160): 108 participants, 24-week home-based resistance program. Muscle thickness by ultrasound. Estimated start Nov 2026.

Until these results arrive, the current best-practice is the Joint Advisory protocol: lift + protein + monitor.

7 Signs You Are Losing Too Much Muscle

Warning signs include visible loss of muscle definition, declining grip strength, increased fatigue during daily activities, feeling colder than usual, slow wound healing, worsening balance, and weight loss exceeding 2 pounds per week.

Not all lean mass loss is created equal. Some is expected and harmless (water, glycogen stores, non-functional tissue). The warning signs that you are losing functional muscle include:

1. Strength is dropping fast. If you could squat 135 lbs last month and now struggle with 95, that is muscle loss outpacing fat loss. Track your key lifts every 2–4 weeks.

2. You are getting tired doing things that used to be easy. Climbing stairs, carrying groceries, getting up from a low chair. If these feel harder, functional muscle is declining.

3. Grip is weakening. Grip strength is one of the best single predictors of overall muscular health and longevity. If jars are harder to open, take notice.

4. Recovery from workouts takes much longer. If soreness lasts 4–5 days instead of 1–2, your muscles are not recovering properly — usually a sign of inadequate protein or overtraining relative to your current capacity.

5. You look "deflated" rather than lean. Losing fat while maintaining muscle gives a firm, toned look. Losing both gives a soft, flat appearance, sometimes called "skinny fat."

6. Your weight is dropping faster than expected. Losing more than 2 lbs per week consistently suggests you are losing more lean tissue than necessary. Discuss dose adjustment with your prescriber.

7. Lab markers are off. Low albumin, declining creatinine (paradoxically), or a dropping BUN-to-creatinine ratio can indicate muscle catabolism. Ask your doctor to include these in your routine monitoring.

5 Common Mistakes That Accelerate Muscle Loss

The five most common mistakes are relying on cardio instead of resistance training, eating too little protein, losing weight too fast, skipping creatine, and not monitoring body composition (using only the scale).

Mistake 1: Doing only cardio. Walking and running burn calories but do not provide the mechanical stimulus muscles need to stay. (Muscle loss also worsens GLP-1 fatigue, since less muscle means lower baseline energy.) Cardio is great for cardiovascular health but is not a substitute for resistance training during weight loss. If you have limited time, lift first, walk second.

Mistake 2: Skipping meals because you are not hungry. GLP-1 drugs suppress appetite. That is their job. But "not hungry" does not mean "do not need nutrients." Skipping meals drops daily protein below the threshold for muscle maintenance. Eat by schedule, not by appetite, at least for protein.

Mistake 3: Relying on a generic multivitamin for nutrition. Standard multivitamins rarely contain adequate protein (zero), creatine (zero), or meaningful doses of iron and zinc. A targeted companion supplement designed for GLP-1 users fills specific gaps, but it does not replace food-based protein.

Mistake 4: Cutting calories further on top of the drug. Some users add intermittent fasting or very low-calorie diets on top of GLP-1 therapy, creating an extreme deficit. This dramatically worsens lean mass loss. The drug is already creating a substantial deficit — do not stack additional restriction on top.

Mistake 5: Ignoring hydration. Dehydration reduces exercise performance by 10–20% and impairs muscle protein synthesis. GLP-1 users already drink less because thirst drops with appetite. Set a daily water target and track it, at least 64 oz, more on training days.

How much muscle do you lose on Ozempic?

In the STEP 1 trial, semaglutide users lost about 9.7% of total lean body mass over 68 weeks. Roughly 5.3 kg. But total fat mass dropped 19.3%, and the lean-to-fat ratio actually improved. About 75% of total weight lost was fat and 25% was lean mass, which is similar to the ratio in any calorie-deficit diet.

Does Mounjaro cause more muscle loss than Ozempic?

SURMOUNT-1 showed tirzepatide users lost 10.9% lean mass versus semaglutide's 9.7% in STEP 1, but tirzepatide also produced more total weight loss (21.3% vs 15.0%). The 75:25 fat-to-lean ratio was similar for both drugs. No head-to-head trial has compared body composition using the same DXA protocol.

Can you build muscle while on Ozempic?

Yes, especially if you are new to resistance training. You are unlikely to build muscle at the rate of someone eating at maintenance, but beginners can experience "newbie gains" even in a calorie deficit.

How much protein should I eat on a GLP-1 drug?

The 2025 Joint Advisory recommends 1.2–1.6 g per kg of body weight daily. For a 180-lb (82 kg) person, that is 98–131 g/day. Distribute it across 3–4 meals, aiming for at least 25–30 g per meal to hit the leucine threshold for muscle protein synthesis.

Does creatine help with muscle loss on Ozempic?

There is no GLP-1-specific creatine trial yet, but two 2025 meta-analyses in older adults doing resistance training showed creatine improved lean mass and strength. A 2026 comprehensive review classified creatine as an "optional adjunct with resistance training" during GLP-1 therapy. It is safe, well-studied, and inexpensive — making it a reasonable addition alongside the core protocol of lifting and protein.

Is muscle loss on GLP-1 drugs permanent?

Not necessarily. Muscle is rebuilt through resistance training and adequate nutrition. However, regaining lost muscle takes longer than losing it, especially for older adults and postmenopausal women. This is why prevention during treatment is far more effective than trying to rebuild afterward. If you stop the drug and regain weight without exercise, the regained weight tends to be disproportionately fat.

References